Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ornstein

Showing results (151-160 of 233) with videos related to

Pageof 24
Sort By:
Seminars in Thrombosis and Hemostasis|March 9, 2002
Treatment of malignancy by activation of the plasminogen systemLeo R Zacharski, Deborah L Ornstein, Esteban C Gabazza, et al.
European Journal of Pharmacology|May 2, 1991
NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawalK Rasmussen, R W Fuller, M E Stockton, et al.
ACS Medicinal Chemistry Letters|June 14, 2023
Excellence in Medicinal Chemistry: Celebrating ACS Medicinal Chemistry Division (MEDI) Awards. A Call for NominationsMaria-Jesus Blanco, Amanda Bryant-Friedrich, Gunda Georg, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1987
Primary structure of bovine pituitary secretory protein I (chromogranin A) deduced from the cDNA sequenceT G Ahn, D V Cohn, S U Gorr, et al.
Military Medicine|January 28, 2003
Allogeneic hematopoietic stem cell transplantation in the active duty military population: 1987-2001Deborah L Ornstein, Brenda L Frye, David Ririe, et al.
Neuropharmacology|December 16, 1998
The GluR5 subtype of kainate receptor regulates excitatory synaptic transmission in areas CA1 and CA3 of the rat hippocampusM Vignes, V R Clarke, M J Parry, et al.
Journal of Medicinal Chemistry|February 17, 1998
2-Substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 1. Effects of alkyl, arylalkyl, and diarylalkyl substitutionP L Ornstein, T J Bleisch, M B Arnold, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
[3H]LY341495, a highly potent, selective and novel radioligand for labeling Group II metabotropic glutamate receptorsP L Ornstein, M B Arnold, T J Bleisch, et al.
Neuropharmacology|October 26, 1999
[3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cellsB G Johnson, R A Wright, M B Arnold, et al.
Neuropharmacology|April 10, 2007
Anxiolytic-like effects through a GLUK5 kainate receptor mechanismAndrew Alt, Brianne Weiss, Paul L Ornstein, et al.
Pageof 24

Showing results (151-160 of 233) with videos related to

Sort By:
Pageof 24
Seminars in Thrombosis and Hemostasis|March 9, 2002
Treatment of malignancy by activation of the plasminogen systemLeo R Zacharski, Deborah L Ornstein, Esteban C Gabazza, et al.
European Journal of Pharmacology|May 2, 1991
NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawalK Rasmussen, R W Fuller, M E Stockton, et al.
ACS Medicinal Chemistry Letters|June 14, 2023
Excellence in Medicinal Chemistry: Celebrating ACS Medicinal Chemistry Division (MEDI) Awards. A Call for NominationsMaria-Jesus Blanco, Amanda Bryant-Friedrich, Gunda Georg, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1987
Primary structure of bovine pituitary secretory protein I (chromogranin A) deduced from the cDNA sequenceT G Ahn, D V Cohn, S U Gorr, et al.
Military Medicine|January 28, 2003
Allogeneic hematopoietic stem cell transplantation in the active duty military population: 1987-2001Deborah L Ornstein, Brenda L Frye, David Ririe, et al.
Neuropharmacology|December 16, 1998
The GluR5 subtype of kainate receptor regulates excitatory synaptic transmission in areas CA1 and CA3 of the rat hippocampusM Vignes, V R Clarke, M J Parry, et al.
Journal of Medicinal Chemistry|February 17, 1998
2-Substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 1. Effects of alkyl, arylalkyl, and diarylalkyl substitutionP L Ornstein, T J Bleisch, M B Arnold, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
[3H]LY341495, a highly potent, selective and novel radioligand for labeling Group II metabotropic glutamate receptorsP L Ornstein, M B Arnold, T J Bleisch, et al.
Neuropharmacology|October 26, 1999
[3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cellsB G Johnson, R A Wright, M B Arnold, et al.
Neuropharmacology|April 10, 2007
Anxiolytic-like effects through a GLUK5 kainate receptor mechanismAndrew Alt, Brianne Weiss, Paul L Ornstein, et al.
Pageof 24